The expression and function of microRNA-203 in lung cancer

Tumor Biology

Volumn 34, Issue 1, 2013, Pages 349-357

  Jin, Jianhua ^a   Deng, Jianzhong ^a   Wang, Fang ^a   Xia, Xiyi ^a   Qiu, Tiefeng ^a   Lu, Wenbin ^a   Li, Xianwen ^a   Zhang, Hua ^a   Gu, Xiaoyan ^a   Liu, Yungang ^a   Cao, Weiguo ^b   Shao, Wenlong ^c  

^a JIANGSU UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Lung cancer; miR 203; Proliferation; Survivin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; LIPOCORTIN 5; LUCIFERASE; MICRORNA; MICRORNA 203; PROPIDIUM IODIDE; SURVIVIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BRONCHUS MUCOSA; CANCER CELL; CANCER CELL CULTURE; CELL ASSAY; CELL COUNT; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; EPITHELIUM CELL; FLOW CYTOMETRY; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; WESTERN BLOTTING;

EID: 84872775850     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0556-3     Document Type: Article

References (43)

1. E Shash FA Peccatori HA Azim Jr 2011 Optimizing the use of epidermal growth factor receptor inhibitors in advanced non-small-lung cancer (NSCLC) J Thorac Dis 3 1 57 64 22263061 1:CAS:528:DC%2BC3MXmtl2msrg%3D
2. G Metro L Crinò 2012 Advances on EGFR mutation for lung cancer Transl Lung Cancer Res 1 1 5 13
3. S Pakkala SS Ramalingam 2010 Lung cancer in HIV-positive patients J Thorac Oncol 5 11 1864 1871 20881639 10.1097/JTO.0b013e3181f387fd
4. TP Lu MH Tsai CK Hsiao LC Lai EY Chuang 2012 Expression and functions of semaphorins in cancer Transl Cancer Res 1 2 74 87
5. C Nieder J Norum 2012 Early palliative care in patients with metastatic non-small cell lung cancer Ann Palliat Med 1 1 84 86
6. LQ Zhang J Wang F Jiang L Xu FY Liu R Yin 2012 Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysis PLoS One 7 3 e34100 22457815 10.1371/journal.pone.0034100 1:CAS:528:DC%2BC38XltF2ktLs%3D
7. WQ Chen SW Zhang XN Zou P Zhao 2011 Cancer incidence and mortality in China, 2006 Chin J Cancer Res 23 1 3 9 10.1007/s11670-011-0003-9 1:CAS:528:DC%2BC3MXht1WntbrI
8. WC You 2011 Contribution from cancer epidemiological studies in China Chin J Cancer Res 23 1 1 2 10.1007/s11670-011-0001-y
9. BJ Park 2012 Robotic lobectomy for non-small cell lung cancer (NSCLC): multi-registry study of long-term oncologic results Ann Cardiothorac Surg 1 1 24 26
10. YX Wang 2011 Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application Quant Imaging Med Surg 1 1 35 40 23256052
11. Y Koga M Yasunaga Y Moriya T Akasu S Fujita S Yamamoto Y Matsumura 2011 Exosome can prevent RNase from degrading microRNA in feces J Gastrointest Oncol 2 4 215 222 22811855 1:CAS:528:DC%2BC38Xps1Grurc%3D
12. N Wall 2011 Colorectal cancer screening using protected microRNAs J Gastrointest Oncol 2 4 206 207 22811853
13. F Meng H Francis G Alpini 2012 Non-coding RNAs in human liver malignancies, critical regulators for cancer stemness? Transl Gastrointest Cancer 1 1 1 4
14. P Knuckles MA Vogt S Lugert M Milo MM Chong GM Hautbergue SA Wilson DR Littman V Taylor 2012 Drosha regulates neurogenesis by controlling neurogenin 2 expression independent of microRNAs Nat Neurosci 15 7 962 969 22706270 10.1038/nn.3139 1:CAS:528:DC%2BC38Xos12htLg%3D
15. GS Shu ZL Yang DC Liu 2012 Immunohistochemical study of Dicer and Drosha expression in the benign and malignant lesions of gallbladder and their clinicopathological significances Pathol Res Pract 208 7 392 397 22658478 10.1016/j.prp.2012.05.001 1:CAS:528:DC%2BC38XhtVCmu7jO
16. GS Tan BG Garchow X Liu D Metzler M Kiriakidou 2011 Clarifying mammalian RISC assembly in vitro BMC Mol Biol 12 19 21529364 10.1186/1471-2199-12-19 1:CAS:528:DC%2BC3MXlvVCrsr4%3D
17. SS Hebert N Sergeant L Buee 2012 MicroRNAs and the regulation of tau metabolism Int J Alzheimers Dis 2012 406561 22720189
18. K Ui-Tei K Nishi T Takahashi T Nagasawa 2012 Thermodynamic control of small RNA-mediated gene silencing Front Genet 3 101 22675333
19. JS Yang T Maurin EC Lai 2012 Functional parameters of Dicer-independent microRNA biogenesis RNA 18 5 945 957 22461413 10.1261/rna.032938.112
20. J Wang LC Li 2012 Small RNA and its application in andrology and urology Transl Androl Urol 1 1 33 43 23002430 1:CAS:528:DC%2BC3MXhsVKhtLzO
21. J Aliotta 2011 Tumor exosomes: a novel biomarker? J Gastrointest Oncol 2 4 203 205 22811852
22. J Yu A Li SM Hong RH Hruban M Goggins 2012 MicroRNA alterations of pancreatic intraepithelial neoplasias Clin Cancer Res 18 4 981 992 22114139 10.1158/1078-0432.CCR-11-2347
23. P Luzna J Gregar I Uberall L Radova V Prochazka J Ehrmann Jr 2011 Changes of microRNAs-192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals Diagn Pathol 6 114 22094011 10.1186/1746-1596-6-114 1:CAS:528:DC%2BC38Xislams70%3D
24. MJ Bueno I Perez de Castro M Gomez de Cedron J Santos GA Calin JC Cigudosa CM Croce J Fernandez-Piqueras M Malumbres 2008 Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression Cancer Cell 13 6 496 506 18538733 10.1016/j.ccr.2008.04.018 1:CAS:528: DC%2BD1cXns1yhtbs%3D
25. N Ikenaga K Ohuchida K Mizumoto J Yu T Kayashima H Sakai H Fujita K Nakata M Tanaka 2010 MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma Ann Surg Oncol 17 12 3120 3128 20652642 10.1245/s10434-010-1188-8
26. JA McKenzie D Grossman 2012 Role of the apoptotic and mitotic regulator survivin in melanoma Anticancer Res 32 2 397 404 22287725 1:CAS:528: DC%2BC38XjsF2lt7g%3D
27. DN Church DC Talbot 2012 Survivin in solid tumors: rationale for development of inhibitors Curr Oncol Rep 14 2 120 128 22234703 10.1007/s11912-012-0215-2 1:CAS:528:DC%2BC38Xjs1Oktrs%3D
28. S Saini S Majid S Yamamura L Tabatabai SO Suh V Shahryari Y Chen G Deng Y Tanaka R Dahiya 2011 Regulatory role of mir-203 in prostate cancer progression and metastasis Clin Cancer Res 17 16 5287 5298 21159887 10.1158/1078-0432.CCR- 10-2619 1:CAS:528:DC%2BC3MXhtVajs7vE
29. AC Gower K Steiling JF Brothers 2nd ME Lenburg A Spira 2011 Transcriptomic studies of the airway field of injury associated with smoking-related lung disease Proc Am Thorac Soc 8 2 173 179 21543797 10.1513/pats.201011-066MS 1:CAS:528:DC%2BC3MXoslertr8%3D
30. M Hassanein JS Rahman P Chaurand PP Massion 2011 Advances in proteomic strategies toward the early detection of lung cancer Proc Am Thorac Soc 8 2 183 188 21543799 10.1513/pats.201012-069MS 1:CAS:528:DC%2BC3MXoslertrw%3D
31. PM Ellis R Vandermeer 2011 Delays in the diagnosis of lung cancer J Thorac Dis 3 3 183 188 22263086
32. GA Calin CD Dumitru M Shimizu R Bichi S Zupo E Noch H Aldler S Rattan M Keating K Rai, et al. 2002 Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia Proc Natl Acad Sci U S A 99 24 15524 15529 12434020 10.1073/pnas.242606799 1:CAS:528: DC%2BD3sXjvVOl
33. WC Cho 2012 MicroRNAs as therapeutic targets and their potential applications in cancer therapy Expert Opin Ther Targets 16 8 747 759 22690697 10.1517/14728222.2012.696102 1:CAS:528:DC%2BC38XhtVKgu7%2FK
34. DK Xiao JX He 2010 Epithelial mesenchymal transition and lung cancer J Thorac Dis 2 3 154 159 22263037 1:CAS:528:DC%2BC3MXmsVKntLs%3D
35. A Izzotti C Cartiglia VE Steele S De Flora 2012 MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis Mutat Res 751 2 287 303 22683846 10.1016/j.mrrev.2012.05.004 1:CAS:528: DC%2BC38XptVKnsLk%3D
36. RL Skalsky DL Corcoran E Gottwein CL Frank D Kang M Hafner JD Nusbaum R Feederle HJ Delecluse MA Luftig, et al. 2012 The viral and cellular microRNA targetome in lymphoblastoid cell lines PLoS Pathog 8 1 e1002484 22291592 10.1371/journal.ppat.1002484 1:CAS:528:DC%2BC38Xit1Chs78%3D
37. L Chen C Li R Zhang X Gao X Qu M Zhao C Qiao J Xu J Li 2011 miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma Cancer Lett 309 1 62 70 21664042 10.1016/j.canlet.2011.05.017 1:CAS:528:DC%2BC3MXotl2luro%3D
38. M Fabbri A Bottoni M Shimizu R Spizzo MS Nicoloso S Rossi E Barbarotto A Cimmino B Adair SE Wojcik, et al. 2011 Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia JAMA 305 1 59 67 21205967 10.1001/jama.2010.1919 1:CAS:528: DC%2BC3MXkslWhsQ%3D%3D
39. C Dong M Ji C Ji 2009 microRNAs and their potential target genes in leukemia pathogenesis Cancer Biol Ther 8 3 200 205 19106636 10.4161/cbt.8.3.7333 1:CAS:528:DC%2BD1MXotV2qsLY%3D
40. E Bostjancic D Glavac 2008 Importance of microRNAs in skin morphogenesis and diseases Acta Dermatovenerol Alp Panonica Adriat 17 3 95 102 18853072
41. F Sato S Tsuchiya SJ Meltzer K Shimizu 2011 MicroRNAs and epigenetics FEBS J 278 10 1598 1609 21395977 10.1111/j.1742-4658.2011.08089.x 1:CAS:528:DC%2BC3MXmsVKktbk%3D
42. K Bian J Fan X Zhang XW Yang HY Zhu L Wang JY Sun YL Meng PC Cui SY Cheng, et al. 2012 MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin FEBS Lett 586 6 804 809 22306317 10.1016/j.febslet.2012.01.050 1:CAS:528:DC%2BC38XitFKhtL8%3D
43. C Wang X Zheng C Shen Y Shi 2012 MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells J Exp Clin Cancer Res 31 58 22713668 10.1186/1756-9966-31-58